Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safe handling and administration of MABS: the guidance.

British journal of nursing (Mark Allen Publishing)·2016
Same author

Peripheral intravenous cannulation: managing distress and anxiety.

British journal of nursing (Mark Allen Publishing)·2014
Same author

Peripheral intravenous cannulation: what is considered "best practice'?

British journal of nursing (Mark Allen Publishing)·2014
Same author

Why use safety needle devices?

British journal of nursing (Mark Allen Publishing)·2013
Same author

Chemo-induced hair loss: prevention of a distressing side-effect.

British journal of nursing (Mark Allen Publishing)·2013
Same author

Peripheral cannulation versus peripheral inserted central catheter.

British journal of nursing (Mark Allen Publishing)·2013

Related Experiment Video

Updated: Jun 10, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Peripheral IV cannulation in chemotherapy administration.

Donna McGowan1

  • 1Edinburgh Cancer Centre, Western General Hospital, Edinburgh.

British Journal of Nursing (Mark Allen Publishing)
|July 22, 2010
PubMed
Summary

Chemotherapy can cause dangerous side effects like low blood counts, increasing infection risk for patients needing IV therapy. Careful infection control is crucial for these vulnerable individuals receiving treatment.

Area of Science:

  • Oncology
  • Hematology
  • Infectious Disease

Background:

  • Chemotherapy often leads to severe toxic side effects, including bone marrow suppression.
  • Bone marrow suppression can manifest as neutropenia, thrombocytopaenia, and anaemia, compromising patient immunity.
  • These hematological toxicities elevate the risk of serious infections, particularly in patients requiring intravenous (IV) access.

Purpose of the Study:

  • To highlight the critical importance of infection control measures in cancer patients undergoing chemotherapy.
  • To underscore the heightened susceptibility to infection in patients experiencing chemotherapy-induced neutropenia, thrombocytopaenia, and anaemia.
  • To emphasize the significance of managing infection risks associated with peripheral intravenous cannulation in this patient cohort.

Main Methods:

More Related Videos

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Related Experiment Videos

Last Updated: Jun 10, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

  • Review of existing literature on chemotherapy side effects and infection risks.
  • Analysis of patient case studies highlighting infection complications.
  • Discussion of current infection control protocols in oncology settings.

Main Results:

  • Chemotherapy-induced bone marrow suppression significantly increases the risk of opportunistic infections.
  • Peripheral intravenous cannulas serve as potential entry points for pathogens in immunocompromised patients.
  • Effective infection control strategies are paramount in reducing morbidity and mortality.

Conclusions:

  • Patients undergoing chemotherapy with resultant bone marrow suppression require stringent infection control protocols.
  • Minimizing infection risks associated with IV therapies is essential for patient safety and treatment adherence.
  • Further research into optimized infection prevention strategies for this vulnerable population is warranted.